The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2023

Filed:

Jul. 08, 2021
Applicant:

Acerta Pharma B.v., Oss, NL;

Inventors:

Ahmed Hamdy, Santa Cruz, CA (US);

Wayne Rothbaum, Delray Beach, FL (US);

Raquel Izumi, San Carlos, CA (US);

Brian Lannutti, Solana Beach, CA (US);

Todd Covey, San Carlos, CA (US);

Roger Ulrich, Sammamish, WA (US);

David M. Johnson, Aptos, CA (US);

Tjeerd Barf, Ravenstein, NL;

Allard Kaptein, Zaltbommel, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/4468 (2006.01); A61K 45/06 (2006.01); A61K 31/675 (2006.01); A61K 31/437 (2006.01); A61P 35/00 (2006.01); A61K 31/454 (2006.01); A61K 31/52 (2006.01); A61K 31/635 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 31/437 (2013.01); A61K 31/4468 (2013.01); A61K 31/454 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/635 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01);
Abstract

Therapeutic combinations of a phosphoinositide 3-kinase (PI3K) inhibitor, including PI3K inhibitors selective for the γ- and δ-isoforms and selective for both γ- and δ-isoforms (PI3K-γ,δ, PI3K-γ, and PI3K-δ), a Janus kinase-2 (JAK-2) inhibitor, a Bruton's tyrosine kinase (BTK) inhibitor, and/or a B-cell lymphoma-2 (BCL-2) inhibitor are described. In some embodiments, the invention provides therapeutic combinations of a PI3K-δ inhibitor and a BTK inhibitor, a JAK-2 and a BTK inhibitor, and a BCL-2 and BTK inhibitor.


Find Patent Forward Citations

Loading…